To examine the relative contribution of each key biomarker to atherosclerosis, we constructed cumulative incidence curves for ApoB, LDL-C, and LDL-TG levels against the cumulative incidence of atherosclerosis in all patients and in patients who were not on statins (Figure 3). The gene discussed is APOB; the disease is atherosclerosis.